Literature DB >> 2670337

Carnitine: metabolism and clinical chemistry.

N Siliprandi1, L Sartorelli, M Ciman, F Di Lisa.   

Abstract

In man carnitine is synthesized from proteic trimethyllysine in liver, brain and kidney. Muscles which contain approximately 98% of carnitine must take it up from the blood in an exchange process with endogenous deoxycarnitine, the immediate precursor of carnitine. Uneven organ distribution of the enzymes catalyzing carnitine synthesis further implies an inter-organ transport of the intermediates. Assay of these intermediates in blood may assist causal definition of carnitine deficiency syndromes. Besides catalyzing the transport of long-chain acyls in mitochondria, carnitine is necessary for the export of intra-mitochondrially produced short-chain acyls and for trapping and elimination of unphysiological acyls (benzoic, pivalic, valproic acids etc.). Unlike the corresponding acyl-CoA, carnitine esters are capable of diffusing across cellular membranes, and may be eliminated in urine, distributed in tissues or both. Assay of physiological and unphysiological carnitine esters in urine is necessary for the diagnosis of carnitine insufficiencies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670337     DOI: 10.1016/0009-8981(89)90267-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Lipid storage myopathy.

Authors:  A A S Rifat Mannan; A M Ralte; M C Sharma; S Gulati; V Kalra; C Sarkar
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

2.  Influence of L-carnitine administration on maximal physical exercise.

Authors:  L Vecchiet; F Di Lisa; G Pieralisi; P Ripari; R Menabò; M A Giamberardino; N Siliprandi
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

Review 3.  Acylcarnitines in intermediary metabolism.

Authors:  A C Sewell; H J Böhles
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

4.  The effects of increasing exercise intensity on muscle fuel utilisation in humans.

Authors:  L J van Loon; P L Greenhaff; D Constantin-Teodosiu; W H Saris; A J Wagenmakers
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

Review 5.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

6.  Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.

Authors:  H Löster; T Keller; J Grommisch; W Gründer
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

7.  Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation.

Authors:  Y Shigematsu; I L Bykov; Y Y Liu; A Nakai; Y Kikawa; M Sudo; M Fujioka
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Carnitine and physical exercise.

Authors:  O J Heinonen
Journal:  Sports Med       Date:  1996-08       Impact factor: 11.136

9.  Muscle carnitine deficiency: adult onset lipid storage myopathy with sensory neuropathy.

Authors:  Wei Zhang; Jianting Miao; Guangyun Zhang; Rui Liu; Dawei Zhang; Qun Wan; Yingxin Yu; Gang Zhao; Zhuyi Li
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

10.  Branched chain amino acids chronic treatment and muscular exercise performance in athletes: a study through plasma acetyl-carnitine levels.

Authors:  E F De Palo; P Metus; R Gatti; O Previti; L Bigon; C B De Palo
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.